Partnerships Drive Access EpiCypher's strategic alliance with New England Biolabs and ongoing licensing deals with Fred Hutch demonstrate routes to broader market access. Leverage these relationships to co-market and drive enterprise adoption, while exploring joint go-to-market with sequencing platforms like PacBio.

Single Molecule Demand The Fiber-seq Kit and CUTANA Fiber-seq platform broaden the addressable market for long-read, multiomic chromatin mapping. Target genomics cores and cancer research groups seeking comprehensive epigenomic workflows; offer bundled kits and workflow support to accelerate purchasing decisions.

Ecosystem Cross Sell Partnerships with PacBio and NEB create downstream sales opportunities for complementary reagents, enzymes, and sequencing workflows. Propose bundled procurement and co-sell motions with sequencing centers and research institutions adopting epigenomics pipelines.

Credibility and Funding Exclusive licensing with a premier cancer center reinforces credibility for enterprise buyers and grant-funded programs. Leverage this to approach large academic medical centers, biotech R&D divisions, and government-funded projects seeking validated epigenomic tools.

Support as Differentiator A dedicated Tech Support Center signals strong post-purchase service. Use this to upsell premium support, training, and on-site onboarding, reducing adoption risk for complex CUTANA and Fiber-seq workflows.